Literature DB >> 5446958

Isolation and identification of 4-ketocyclophosphamide, a possible active form of the antitumor agent cyclophosphamide.

D L Hill, M C Kirk, R F Struck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5446958     DOI： 10.1021/ja00713a060

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN： 0002-7863            Impact factor:   15.419


× No keyword cloud information.
  6 in total

Review 1.  [Metabolic pathways of cyclophosphamide].

Authors:  K Norpoth; H M Rauen
Journal:  Klin Wochenschr       Date:  1972-05-01

2.  Oxidation of cyclophosphamide by means of KMnO 4 .

Authors:  K Norpoth; J Knippschild; U Witting; H M Rauen
Journal:  Experientia       Date:  1972-05-15

Review 3.  Problems with immunosuppressive agents in renal disease.

Authors:  J S Cameron
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1975

4.  Enzymatic toxicogenation of "activated" cyclophosphamide by 3'-5' exonucleases.

Authors:  L Bielicki; G Voelcker; H J Hohorst
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

5.  Lymphocyte deactivation by (potential immunosuppressant) alkylating metabolites of cyclophosphamide.

Authors:  M W Whitehouse; F W Beck; M M Dröge; R F Struck
Journal:  Agents Actions       Date:  1974-04

6.  Interactions of Some Chemotherapeutic Agents as Epirubicin, Gemcitabine and Paclitaxel in Multicomponent Systems Based on Orange Essential Oil.

Authors:  Adriana Samide; Bogdan Tutunaru; Renata-Maria Varut; Bogdan Oprea; Simona Iordache
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.